Locally-based medicinal cannabis company, ANTG, has been selected as a finalist in the Regional Exporter category for the 2024 Premier’s NSW Export Awards.
According to antg.com.au, the company has expanded significantly around Australia since starting in 2016, and is a ‘premier producer of high-quality medical cannabis, committed to advancing the industry through innovation, sustainability, and excellence’.
Matt Cantelo, Founder and CEO of ANTG, said the achievement reinforces ‘its standing in the European market through an exclusive agreement with Cannamedical Pharma (CM), valued at over $100 million. CM, the largest independent producer and distributor of medical cannabis in Germany, operates in Europe’s fastest-growing cannabis market’.
‘The increase in production and manufacturing capacity represents a significant boost for the regional economy, expected to create up to 45 new local jobs in cultivation and manufacturing.
‘In 2020, ANTG became the first Australian company to export commercially cultivated flower, to Germany and has continued this successful partnership as the country enters a new era of cannabis law reform. In April, comprehensive legislation was passed, removing prescription cannabis-based medicines from the narcotics list and further expanding patient access to the medical market.
‘The contract marks a major expansion of ANTG’s domestic operations in the Northern Tablelands region’, said Mr Cantelo.
For four decades The Echo has printed the stories some people loved, some people hated, and some pretended not to read. If you want us to keep telling the truth, the real truth, not the sugar-coated version. We’ll need your support to keep the presses rolling. 
